What Is the evidence from past National Institute of Health and Care Excellence single-technology appraisals regarding company submissions with base-case incremental cost-effectiveness ratios of less than £10,000/QALY?

Carroll, C. orcid.org/0000-0002-6361-6182, Houten, R., Boland, A. et al. (2 more authors) (2017) What Is the evidence from past National Institute of Health and Care Excellence single-technology appraisals regarding company submissions with base-case incremental cost-effectiveness ratios of less than £10,000/QALY? Value in Health. ISSN 1098-3015

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Elsevier. This is an author produced version of a paper subsequently published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Base-case ICERs; health policy; National Institute for Health and Care Excellence (NICE); single-technology appraisals (STAs)
Dates:
  • Published (online): 18 October 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 03 Nov 2017 11:49
Last Modified: 18 Oct 2018 00:38
Published Version: https://doi.org/10.1016/j.jval.2017.09.006
Status: Published online
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2017.09.006

Share / Export

Statistics